19683 research outputs found
Sort by
The Looking Glass : New Perspectives on Children's Literature
No full textThis journal considers all aspects of children's and young adult literature: critical analysis, authorship, illustration, publishing, as well as social and cultural influences.
"The Looking Glass: new perspectives in children's literature (ISSN 1551-5680) ... was first published as a set of webpages in 1997, its parent organization was the Toronto Centre for the Study of Children's Literature (TCSCL), then housed at the Faculty of Information Studies, University of Toronto. From July 1998, it was independent of any institutional support and was published by volunteers in the United States. In 2007 La Trobe University in Australia began providing hosting and technical support, utilising the [now de-commissioned] OJS open access journal system."
-- The description above was taken from "Open Access and Web 2.0 in the Academy: Changing and Exchanging Scholarship in Children's Literature" by David Beagley - see https://doi.org/10.26181/22200340
Journal Issues:
The Looking Glass. Vol. 22 No. 1 (2019)
The Looking Glass. Vol. 21 No. 1 (2018)
The Looking Glass. Vol. 20 No. 1 (2017)
The Looking Glass. Vol. 19 No. 1 (2016)
The Looking Glass. Vol. 18 No. 2 (2015)
The Looking Glass. Vol. 18 No. 1 (2015)
The Looking Glass. Vol. 17 No. 3 (2014)
The Looking Glass. Vol. 17 No. 2 (2014)
The Looking Glass. Vol. 17 No. 1 (2013)
The Looking Glass. Vol. 16 No. 2 (2012)
The Looking Glass. Vol. 16 No. 1 (2012)
The Looking Glass. Vol. 15 No. 3 (2011)
The Looking Glass. Vol. 15 No. 2 (2011)
The Looking Glass. Vol. 15 No. 1 (2011)
The Looking Glass. Vol. 14 No. 2 (2010)
The Looking Glass. Vol. 14 No. 1 (2010)
The Looking Glass. Vol. 13 No. 3 (2009)
The Looking Glass. Vol. 13 No. 2 (2009)
The Looking Glass. Vol. 13 No. 1 (2009)
The Looking Glass. Vol. 12 No. 2 (2008)
The Looking Glass. Vol. 12 No. 1 (2008)
The Looking Glass. Vol. 11 No. 3 (2007)
The Looking Glass. Vol. 11 No. 2 (2007)
The Looking Glass. Vol. 11 No. 1 (2007)
The Looking Glass. Vol. 10 No. 3 (2006)
The Looking Glass. Vol. 10 No. 2 (2006)
The Looking Glass. Vol. 10 No. 1 (2006)
The Looking Glass. Vol. 9 No. 3 (2005)
The Looking Glass. Vol. 9 No. 2 (2005)
The Looking Glass. Vol. 9 No. 1 (2005)
The Looking Glass. Vol. 8 No. 3 (2004)
The Looking Glass. Vol. 8 No. 2 (2004)
The Looking Glass. Vol. 8 No. 1 (2004)
The Looking Glass. Vol. 7 No. 3 (2003)
The Looking Glass. Vol. 7 No. 2 (2003)
The Looking Glass. Vol. 7 No. 1 (2003)
The Looking Glass. Vol. 6 No. 1 (2002)
The Looking Glass. Vol. 5 No. 1 (2001)
The Looking Glass. Vol. 4 No. 3 (2000)
The Looking Glass. Vol. 4 No. 2 (2000)
The Looking Glass. Vol. 4 No. 1 (2000)
The Looking Glass. Vol. 3 No. 3 (1999)
The Looking Glass. Vol. 3 No. 2 (1999)
The Looking Glass. Vol. 3 No. 1 (1999)
The Looking Glass. Vol. 2 No. 3 (1998)
The Looking Glass. Vol. 2 No. 2 (1998)
The Looking Glass. Vol. 2 No. 1 (1998)
The Looking Glass. Vol. 1 No. 4 (1997)
The Looking Glass. Vol. 1 No. 3 (1997)
The Looking Glass. Vol. 1 No. 2 (1997)
The Looking Glass. Vol. 1 No. 1 (1997)
</ul
How ‘Dark Spirituality’ can light the way for troubled youth
No full textFor The Australian subscription log in access: https://www.theaustralian.com.au/inquirer/how-dark-spirituality-can-light-the-way-for-troubled-youth/news-story/a7d2b504467e9ef67ba1a684a0cdf93d </p
Exploring decolonial feminist approaches through arts-based research on sexual and reproductive health and rights in the Philippines
No full textNo description supplied</p
Detection of cognitive impairment, dementia and associated risk factors among Aboriginal and Torres Strait Islander peoples: Retrospective baseline audit results from a stepped‐wedge cluster‐randomised controlled trial
No full textOBJECTIVE: Aboriginal and Torres Strait Islander peoples experience high rates of dementia, cognitive impairment not dementia (CIND) and associated risk factors. The objective of this paper is to outline baseline audit results of documented dementia, CIND and associated risk factors in patients attending Aboriginal Community-Controlled Health Organisations (ACCHOs). METHODS: Twelve ACCHOs in urban, regional and remote locations across Queensland, New South Wales, Victoria and Western Australia participated in the study. A specialised audit tool identified documented CIND, dementia and risk factors. Medical record audits of 1655 clients aged 50 years or older for the period from 1 September 2016 to 31 January 2019 were completed. RESULTS: The mean age of patients was 60.3 ± 8.2 years, and 57% were female. The overall prevalence of documented CIND or dementia was low, noted for only 67 (4%) patients. The prevalence of risk factors was high, with over two thirds (71%, n = 1168) of the cohort having ≥4 risk factors associated with dementia and CIND. These included high rates of hypertension (56%), diabetes (45%), dyslipidaemia (48%), obesity (40%) and current smoking (42%). CONCLUSIONS: There was a low detection of CIND and dementia accompanied by a high prevalence of associated risk factors in this primary health-care setting. These findings highlight the need to improve dementia and CIND detection in Aboriginal and Torres Strait Islander patient groups across varied geographical settings. The findings also provide insights into risk factor prevalence to inform management strategies. Responsive models of cognitive care that are culturally appropriate and co-designed with ACCHOs are required to address this need.</p
Neuropathic Symptoms and Frequency of Chronic Pain in an International Online Sample of Individuals with Sub-Acute and Chronic Stroke
No full textBackground/Objectives: Chronic pain is common following a stroke and is associated with increased disability. Yet, little is known about the chronic pain experience in the stroke population. This study aimed to identify and explore the features and neuropathic symptoms of chronic pain in individuals with longstanding stroke. Methods: This observational study utilized an online survey that was developed for individuals who have had a stroke (>3 months). Data sought included participant demographics, medical history, and details of the stroke(s). Participants who reported experiencing chronic pain completed the Numerical Rating Scale for Pain, the Neuropathic Pain Symptom Inventory, and body maps to indicate region(s) of pain. Results: A total of 533 individuals with longstanding stroke participated. Chronic pain was reported as being experienced by 60% of participants and was more frequently experienced by individuals who reported being female (p = 0.002). Moderate or severe pain intensity was commonly reported (mean = 5.98, SD = 1.89). Individuals with chronic pain post-stroke reported a range of neuropathic symptoms rather than a common pain experience, with combinations of spontaneous, paroxysmal, and evoked pains in addition to pain associated with paraesthesia/dysaesthesia. Pain involving the upper limb was the most common region (shoulder 39%, hand and forearm 38%), followed by the lower limb (foot 30%, leg 29%). Having multiple strokes was associated with a higher frequency of chronic pain (p = 0.01), as was peripheral vascular disease (p Conclusions: These findings highlight the varied nature of chronic pain experienced by individuals following a stroke, while also detailing stroke and medical history associated with chronic pain. It builds on existing knowledge of chronic pain post-stroke and provides new insight into the neuropathic symptoms experienced. This knowledge has the potential to assist in the development of tailored interventions based on addressing pain symptomatology and health literacy.</p
Harnessing Plant-Derived Terpenoids for Novel Approaches in Combating Bacterial and Parasite Infections in Veterinary and Agricultural Settings
No full textThe rising resistance to conventional antimicrobial therapies in veterinary contexts poses a formidable challenge. While various innovative treatment strategies for pathogenic infections have emerged, their success still needs to be improved, warranting continued research. Recent investigations into natural products as potential sources for biologically active therapeutics have gained traction. Phytochemicals present a promising alternative in combating a spectrum of pathogens, including bacteria, fungi and parasites. One such class of phytochemicals with mounting potential is the structurally diverse terpenes. These chemicals contribute to plants’ characteristic odour and medicinal effects and have been widely investigated in the scientific literature for their exceptional antibacterial activity. Their efficacy is demonstrated through diverse mechanisms, encompassing damage to bacterial membranes, suppression of virulence factors, and interference with enzymes, toxins, and biofilm formation. This review comprehensively examines terpenes’ in vitro and in vivo activity and their derivatives against pathogens, elucidating their potential against antimicrobial resistance (AMR) and the underlying mechanisms specific to each terpene class. The findings underscore the burgeoning potential of terpene therapy as a viable alternative or supplementary approach to conventional antibiotics in addressing bacterial and parasitic infections in livestock and companion animals.</p
Beijing Wants to Erase Tibet’s Name. Don’t Let Them.
No full textIn this essay we argue, Beijing is attempting to fundamentally alter the global public understanding of Tibet, and is doing so by adopting a well-honed strategy of linguistic imperialism, one that operates at three separate levels: the discursive, the territorial, and the civilizational. But why is Beijing intent on displacing a name with deep history and wide usage, and why is it unwilling to let Tibet stand as the name of the Tibetan people’s homeland?</p
Deep_Time_Detectives_Excavation_Evidence_Logs
No full textThese files are the excavation evidence logs that will be used by your students during the simulated desktop excavation. Full details are available in the Teacher Resource Booklet.Deep Time Detectives: Discover, Analyse, Interpret. © 2025 by Stannard, G.L., E. Mein, L. Ahoy, M.W. Moore, R. Patrick and V. Weisbecker 2025 is licensed under CC BY-NC-SA 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/</p
Investigating Antigen Presentation and the in vivo role of Rho-associated Kinase 1 (ROCK1) in the Apoptotic Cell Disassembly Process
No full textA thesis submitted in total fulfillment of the requirements for the degree of Doctor of Philosophy to the School of Agriculture, Biomedicine and Environment, La Trobe University, Victoria, Australia.This thesis was a recipient of the Nancy Millis Award for theses of exceptional merit.</p
GS-1 blocks entry of herpes viruses and more broadly inhibits enveloped viruses
No full textVaricella-Zoster Virus (VZV) and Herpes Simplex Virus (HSV) are significant global health concerns, infecting over 66% of the population. VZV causes varicella (chickenpox) and herpes zoster (shingles), while HSV leads to oral and genital herpes. Current antiviral treatments target viral replication but face limitations, such as the need for early intervention and the development of drug resistance, particularly in immunocompromised patients. Additionally, while shingles vaccines exist, their use is limited by availability, access, awareness, and cost. There is no vaccine for HSV. This study introduces GS-1, a novel formulation of undecylenic acid compounded with L-Arginine, as an entry inhibitor of enveloped viruses. In vitro studies demonstrate the antiviral activity of GS-1 against both VZV and HSV-1, with EC50 values ranging from 26 μg/mL to 62 μg/mL. Additionally, GS-1 displayed antiviral activity against VZV in an ex vivo human skin model, indicating its potential as a topical antiviral agent. The unique mechanism of action of GS-1, which involved binding directly to viral particles and blocking viral entry, was also extended to another enveloped virus, zika virus (ZIKV), a member of the flavivirus family, but had limited ability to block the non-enveloped virus, rotavirus. GS-1 could offer an effective means of controlling viral infections, particularly when used as combination therapy with other antiviral agents. Future studies will focus on confirming these results in a clinical setting.</p